The University of Chicago Header Logo

Connection

Stephen Kent to Animals

Back to Details
This is a "connection" page, showing publications Stephen Kent has written about Animals.
Stephen Kent
Connection Strength
1.005
Animals
  1. Poor protective potential of influenza nucleoprotein antibodies despite wide prevalence. Immunol Cell Biol. 2022 01; 100(1):49-60.
    View in: PubMed
    Score: 0.045
  2. Protective efficacy of the anti-HIV broadly neutralizing antibody PGT121 in the context of semen exposure. EBioMedicine. 2021 Aug; 70:103518.
    View in: PubMed
    Score: 0.044
  3. Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity. Adv Healthc Mater. 2021 05; 10(10):e2002142.
    View in: PubMed
    Score: 0.043
  4. The protective potential of Fc-mediated antibody functions against influenza virus and other viral pathogens. Immunol Cell Biol. 2020 04; 98(4):253-263.
    View in: PubMed
    Score: 0.040
  5. Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies. Adv Healthc Mater. 2019 05; 8(9):e1801607.
    View in: PubMed
    Score: 0.038
  6. MAIT Cells Upregulate a4ß7 in Response to Acute Simian Immunodeficiency Virus/Simian HIV Infection but Are Resistant to Peripheral Depletion in Pigtail Macaques. J Immunol. 2019 04 01; 202(7):2105-2120.
    View in: PubMed
    Score: 0.037
  7. Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques. J Clin Invest. 2019 01 02; 129(1):182-191.
    View in: PubMed
    Score: 0.037
  8. Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection. Viruses. 2018 06 18; 10(6).
    View in: PubMed
    Score: 0.036
  9. Racemic & quasi-racemic protein crystallography enabled by chemical protein synthesis. Curr Opin Chem Biol. 2018 10; 46:1-9.
    View in: PubMed
    Score: 0.035
  10. HIV Reactivation after Partial Protection by Neutralizing Antibodies. Trends Immunol. 2018 05; 39(5):359-366.
    View in: PubMed
    Score: 0.035
  11. Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection. Sci Transl Med. 2017 Aug 09; 9(402).
    View in: PubMed
    Score: 0.034
  12. Reinvestigation of the biological activity of d-allo-ShK protein. J Biol Chem. 2017 07 28; 292(30):12599-12605.
    View in: PubMed
    Score: 0.033
  13. Antibody-dependent cellular cytotoxicity and influenza virus. Curr Opin Virol. 2017 02; 22:89-96.
    View in: PubMed
    Score: 0.032
  14. Chemical synthesis and enzymatic properties of RNase A analogues designed to enhance second-step catalytic activity. Org Biomol Chem. 2016 Sep 21; 14(37):8804-8814.
    View in: PubMed
    Score: 0.032
  15. Elucidation of the Covalent and Tertiary Structures of Biologically Active Ts3 Toxin. Angew Chem Int Ed Engl. 2016 07 18; 55(30):8639-42.
    View in: PubMed
    Score: 0.031
  16. Influenza-Specific Antibody-Dependent Phagocytosis. PLoS One. 2016; 11(4):e0154461.
    View in: PubMed
    Score: 0.031
  17. Simian immunodeficiency virus infection and immune responses in the pig-tailed macaque testis. J Leukoc Biol. 2015 Mar; 97(3):599-609.
    View in: PubMed
    Score: 0.028
  18. Editorial overview: synthetic biomolecules. Curr Opin Chem Biol. 2014 Oct; 22:viii-xi.
    View in: PubMed
    Score: 0.028
  19. Total chemical synthesis of biologically active fluorescent dye-labeled Ts1 toxin. Angew Chem Int Ed Engl. 2014 Aug 18; 53(34):8970-4.
    View in: PubMed
    Score: 0.027
  20. Native chemical ligation at Asx-Cys, Glx-Cys: chemical synthesis and high-resolution X-ray structure of ShK toxin by racemic protein crystallography. J Am Chem Soc. 2013 Aug 14; 135(32):11911-9.
    View in: PubMed
    Score: 0.025
  21. Racemic protein crystallography. Annu Rev Biophys. 2012; 41:41-61.
    View in: PubMed
    Score: 0.023
  22. Mucosal vaccination against SARS-CoV-2 using recombinant influenza viruses delivering self-assembling nanoparticles. Vaccine. 2025 02 06; 46:126668.
    View in: PubMed
    Score: 0.014
  23. Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery. Int J Pharm. 2024 Nov 15; 665:124695.
    View in: PubMed
    Score: 0.014
  24. The Role of Dorsal Raphe Nucleus Serotonergic Systems in Emotional Learning and Memory in Male BALB/c Mice. Neuroscience. 2023 12 01; 534:1-15.
    View in: PubMed
    Score: 0.013
  25. Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine. EBioMedicine. 2023 Jun; 92:104574.
    View in: PubMed
    Score: 0.013
  26. Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques. PLoS Pathog. 2022 10; 18(10):e1010891.
    View in: PubMed
    Score: 0.012
  27. Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles. Sci Immunol. 2022 01 28; 7(67):eabf5314.
    View in: PubMed
    Score: 0.011
  28. A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2. EBioMedicine. 2021 Dec; 74:103729.
    View in: PubMed
    Score: 0.011
  29. Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain. Cell Rep. 2021 10 12; 37(2):109822.
    View in: PubMed
    Score: 0.011
  30. Quantitatively Tracking Bio-Nano Interactions of Metal-Phenolic Nanocapsules by Mass Cytometry. ACS Appl Mater Interfaces. 2021 Aug 04; 13(30):35494-35505.
    View in: PubMed
    Score: 0.011
  31. Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice. Proc Natl Acad Sci U S A. 2021 05 11; 118(19).
    View in: PubMed
    Score: 0.011
  32. A Non-immunogenic Bivalent d-Protein Potently Inhibits Retinal Vascularization and Tumor Growth. ACS Chem Biol. 2021 03 19; 16(3):548-556.
    View in: PubMed
    Score: 0.011
  33. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nat Rev Immunol. 2020 12; 20(12):727-738.
    View in: PubMed
    Score: 0.011
  34. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. 2020 10; 5(10):1185-1191.
    View in: PubMed
    Score: 0.010
  35. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med. 2020 09; 26(9):1428-1434.
    View in: PubMed
    Score: 0.010
  36. Sequencing B cell receptors from ferrets (Mustela putorius furo). PLoS One. 2020; 15(5):e0233794.
    View in: PubMed
    Score: 0.010
  37. Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation. JCI Insight. 2020 05 21; 5(10).
    View in: PubMed
    Score: 0.010
  38. A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface. Cell. 2019 05 16; 177(5):1136-1152.e18.
    View in: PubMed
    Score: 0.010
  39. Inducible Bronchus-Associated Lymphoid Tissues (iBALT) Serve as Sites of B Cell Selection and Maturation Following Influenza Infection in Mice. Front Immunol. 2019; 10:611.
    View in: PubMed
    Score: 0.009
  40. Identification of murine antigen-specific T follicular helper cells using an activation-induced marker assay. J Immunol Methods. 2019 04; 467:48-57.
    View in: PubMed
    Score: 0.009
  41. Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem. J Clin Invest. 2019 02 01; 129(2):850-862.
    View in: PubMed
    Score: 0.009
  42. Minimum information reporting in bio-nano experimental literature. Nat Nanotechnol. 2018 09; 13(9):777-785.
    View in: PubMed
    Score: 0.009
  43. Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine. Hum Gene Ther. 2018 09; 29(9):1011-1028.
    View in: PubMed
    Score: 0.009
  44. Involvement of Serotonergic and Relaxin-3 Neuropeptide Systems in the Expression of Anxiety-like Behavior. Neuroscience. 2018 10 15; 390:88-103.
    View in: PubMed
    Score: 0.009
  45. A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun. 2018 07 10; 9(1):2669.
    View in: PubMed
    Score: 0.009
  46. Templated Polymer Replica Nanoparticles to Facilitate Assessment of Material-Dependent Pharmacokinetics and Biodistribution. ACS Appl Mater Interfaces. 2017 Oct 04; 9(39):33683-33694.
    View in: PubMed
    Score: 0.008
  47. Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection. EBioMedicine. 2017 May; 19:119-127.
    View in: PubMed
    Score: 0.008
  48. Perplexing cooperative folding and stability of a low-sequence complexity, polyproline 2 protein lacking a hydrophobic core. Proc Natl Acad Sci U S A. 2017 02 28; 114(9):2241-2246.
    View in: PubMed
    Score: 0.008
  49. Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field. Curr HIV Res. 2017; 15(3):202-215.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.